BLUEBIRD BIO (BLUE) Covered Calls

BLUEBIRD BIO covered calls bluebird bio Inc develops, manufactures and markets therapies to deliver genes useful in the treatment of human diseases. Its products portfolio consists of Lenti-D, to treat CCALD;; and LentiGlobin, to treat B-thalassemia and SCD.

You can sell covered calls on BLUEBIRD BIO to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BLUE (prices last updated Tue 2:00 PM ET):

BLUEBIRD BIO (BLUE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
130.43 +5.65 130.37 130.48 387K - 6.8B
Covered Calls For BLUEBIRD BIO (BLUE)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 130 3.50 126.98 2.4% 219%
Nov 16 130 10.60 119.88 8.4% 95.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

bluebird bio, Inc. is a clinical-stage biotechnology company. The company develops next generation products based on the transformative potential of gene therapy to treat patients with severe genetic and orphan diseases. It has two clinical-stage programs in development for childhood cerebral adrenoleukodystrophy and beta-thalassemia/sickle cell disease and a preclinical oncology program in the chimeric antigen receptor T cells field. bluebird bio was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.